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Polychlorinated biphenyls (PCBs) are
synthetic chemicals that were widely used in
electrical transformers, inks, plastics, and
other consumer products. A total of 209 PCB
congeners can be produced depending on the
number of chlorine atoms and their position
on the biphenyl structure. PCBs are lipophilic
and persistent in the environment and bioac-
cumulate in animals and humans. Although
PCBs have been banned in the United States
since the 1970s, they can still be measured in
most U.S. residents [Centers for Disease
Control and Prevention (CDC) 2005]. 
Several epidemiologic studies have
reported that prenatal exposure to PCBs is
associated with poorer neurodevelopment in
neonates, toddlers, and school-age children
(Grandjean et al. 2001; Jacobson and Jacobson
1996; Jacobson et al. 1985, 1990; Koopman-
Esseboom et al. 1996; Rogan and Gladen
1991; Rogan et al. 1986). These ﬁndings are
consistent with animal studies in rodents and
rhesus monkeys, which found that in utero
exposure to PCBs was related to poorer
discrimination reversal learning and spatial
learning (Levin et al. 1988; Schantz et al.
1989; Widholm et al. 2004). Together with
altered neuronal Ca2+ signaling (Wong et al.
1997) and reduced dopamine levels (Seegal
et al. 1991), disruption of thyroid hormone
(TH) homeostasis, which is essential for nor-
mal brain development, has been proposed as a
potential mechanism for the deleterious neu-
rodevelopmental effects of PCBs. In animals,
hypothyroidism affects neuronal proliferation,
migration, myelination, and synaptogenesis
(Ibarrola and Rodriguez-Pena 1997; Nicholson
and Altman 1972; Rami and Rabie 1990). In
humans, maternal thyroid status may be of
critical importance for fetal neurodevelopment
(Haddow et al. 1999; Man and Serunian
1976; Pop et al. 1999), and iodine defi-
ciency–related hypothyroidism is a known
cause of cretinism, the leading preventable
cause of mental retardation worldwide (Dunn
1993). Congenital hypothyroidism, associated
with a variety of pathologies resulting in
insufficient TH levels, can also lead to
neurodevelopmental problems (de Vilder and
Vulsma 2000; Kempers et al. 2006). For this
reason, TH levels are routinely measured as
part of neonatal screening programs so that
TH supplements are administered promptly
if necessary.
Several studies suggest that PCBs may
disrupt TH levels. PCBs, and especially their
hydoxylated metabolites (OH-PCBs), are
structurally similar to thyroxine (T4). Some
PCB congeners reportedly induce the micro-
somal enzyme uridinediphosphate glucurono-
syltransferase (UDP-GT), which catalyzes the
glucuronidation of T4 (Hood et al. 2003; Liu
et al. 1995). Additionally, dioxin-like PCB
congeners can bind to the aryl hydrocarbon
receptor, resulting in the induction of the
cytochrome P450 CYP1A1 as well as the
UDP-GT isoenzyme UGT1A6 (methyl-
cholanthrene-like inducers), which together
with UGT1A1 is responsible for the glu-
curonidation of T4 in rats (Visser et al. 1993).
Other PCB congeners have a phenobarbital-
like induction pattern which is characterized
by the induction of CYP2B and UGT1A1
(Sugatani et al. 2001). PCBs inducing
CYP1A and CYP2B are therefore likely to
also induce UDP-GT.
In animals, in utero exposure to PCB mix-
tures as well as to individual PCB congeners
decreases free and total T4 blood levels. Morse
et al. (1996) exposed rats to the commercial
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BACKGROUND: Studies have reported that prenatal exposure to polychlorinated biphenyls (PCBs)
may alter neurodevelopment in both humans and animals. Furthermore, prenatal exposure to some
PCB congeners and commercial mixtures has been shown to decrease free and total thyroxine (T4)
blood levels in animals. Because thyroid hormones (TH) are essential for normal neurologic devel-
opment, it has been suggested that the deleterious neurodevelopmental effect of PCBs may occur
through TH disruption. PCBs may in turn affect TH levels by inducing the microsomal enzyme
uridinediphosphate glucuronosyltransferase (UDP-GT), which is involved in TH elimination. 
OBJECTIVES: Our goals were to group PCB congeners based on their potential to induce microsomal
enzymes in animals, and to examine the relationship between neonatal TSH levels and prenatal expo-
sure to PCB congeners grouped according to their structure and potential mechanisms of action.
METHODS: We measured the concentration of 34 PCB congeners in serum samples collected from
285 pregnant women and the thyroid-stimulating hormone (TSH) levels in their children’s blood
collected shortly after birth. 
RESULTS: We found no association between the sum of PCB congeners, the toxic equivalents, or
structure-based groupings (mono- or di-ortho substituted congeners), and TSH blood concentra-
tion. However, we found a positive association between the sum of congeners suspected to be
UDP-GT inducers (more speciﬁcally cytochrome P450 2B inducers) in animals and neonatal TSH
levels. In individual congener analyses, PCBs 99, 138, 153, 180, 183, 187, 194, and 199 were posi-
tively associated with neonatal TSH levels after adjustment for covariates. PCBs 194 and 199
remained signiﬁcant after adjustment for multiple hypothesis testing. 
CONCLUSIONS: Our results support grouping PCB congeners based on their potential mechanism
of action of enzyme induction when investigating associations with TH. Findings also suggest that
PCBs affect TH homeostasis even at the low background level of exposure found in the CHAMA-
COS (Center for the Health Assessment of Mothers and Children of Salinas) population.
KEY WORDS: cytochrome P450, enzyme inducers, in utero, microsomal enzymes, neonatal, poly-
chlorinated biphenyls, prenatal, thyroid hormone, TSH, UDP-glucuronosyltransferase. Environ
Health Perspect 115:1490–1496 (2007). doi:10.1289/ehp.9843 available via http://dx.doi.org/
[Online 29 June 2007]PCB mixture Aroclor 1254 from days 10 to
16 of gestation and found a dose-related
reduction in circulating total and free T4 in
fetuses on gestation day 20 and pups on post-
natal days 4 and 21. Similar results were
obtained with PCB-77 in mice (Darnerud
et al. 1996) and OH-PCBs in rats (Meerts
et al. 2002).
Human studies suggest a relationship
between PCBs and TH, but results differ
depending on the PCB congeners studied, the
grouping schemes used, and whether TH and
PCB levels have been examined in the pla-
centa, maternal, cord, or infant blood. For
example, Osius et al. (1999) reported positive
associations between PCB-118 and thyroid-
stimulating hormone (TSH) both measured
in children (n = 320) as well as negative asso-
ciations between PCBs 138, 153, 180, 183,
and 187, and the sum of seven congeners, and
free triiodothyronine (T3). Takser et al.
(2005) found negative associations between
PCBs 138, 153, 180, and the sum of 11 con-
geners, and total T3 in 101 pregnant women,
but did not find associations with TSH. In
another study, the sum of PCB congeners
measured in 160 maternal serum and breast
milk samples was not associated with cord
blood total T4, free T4, or TSH levels
(Longnecker et al. 2000). Ribas-Fito et al.
(2003) measured seven PCB congeners (28,
52, 101, 118, 138, 153, and 180) in 70 cord
blood samples and found no signiﬁcant associ-
ation of their individual or summed concen-
trations with TSH in 3-day-olds. In the only
study to measure TSH in neonates in relation
to maternal PCB exposure, Koopman-
Esseboom et al. (1994) reported significant
positive correlations between the nonplanar
PCB toxic equivalent (TEQ) measured in
breast milk and TSH levels in 2-week-olds
and between the planar PCB TEQ, the dioxin
TEQ, and the PCB–dioxin TEQ, and infant
TSH levels at 2 weeks and 3 months of age. 
Animal studies suggest that PCB con-
geners differ in their mechanisms of action
and in their toxicologic potencies (Desaulniers
et al. 1997; Khan and Hansen 2003; Li et al.
2001) leading some researchers to develop
mechanism-based congener groupings. One
such grouping is based on congeners’ dioxin-
like properties using a method to weigh them
by their toxic equivalencies relative to 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) (Van
den Berg et al. 2006). Wolff et al. (1997) pro-
posed three groups of PCB congeners based on
potential mechanisms of action, structure–
activity considerations as well as occurrence in
house dust and human samples: Group 1
included PCB congeners that are potentially
estrogenic; group 2 included congeners that are
potentially antiestrogenic, immunotoxic, and
dioxin-like; and group 3 included microsomal
enzyme inducers. To date, PCB congeners have
not been grouped based on their potential to
disrupt TH homeostasis.
Although other mechanisms may be
involved, current evidence seems to support
the hypothesis that the reduced T4 levels
caused by PCBs in animals occurs at least in
part through the induction of UDP-GT. An
increase in biliary T4–glucuronide excretion
has been reported following treatment of
rodents with PCBs (Bastomsky 1974).
Furthermore, administration of Aroclor 1254
to thyrodectomized rats implanted with
osmotic pumps delivering T4 resulted in a
reduction of total T4 and free T4 by 75% and
70%, respectively, supporting an extrathy-
roidal mechanism of action (Barter and
Klaassen 1992). Among all UDP-GT induc-
ers tested in the study, UDP-GT activity was
negatively correlated with serum total and free
T4 levels, supporting the hypothesis that
induction of this microsomal enzyme con-
tributes to the PCB-related reduction in
circulating TH levels.
The purpose of the present investigation is
twofold: to group PCB congeners based on
their potential to induce microsomal enzymes
in animals; and to examine the relation
between neonatal TSH and prenatal exposure
to PCB congeners grouped according to their
structure and potential mechanisms of actions.
Methods
Participants. Data for this study were col-
lected as part of the Center for the Health
Assessment of Mothers and Children of
Salinas (CHAMACOS), a longitudinal birth
cohort study investigating environmental
exposures and the health of pregnant women
and children residing in the agricultural
Salinas Valley, California. Pregnant women
planning to deliver at Natividad Medical
Center (NMC), a county hospital located in
Salinas, California, and receiving prenatal care
in this hospital or at one of five clinics of
Clinica de Salud del Valle de Salinas were
screened for enrollment between October
1999 and October 2000. Women were eligi-
ble to participate if they were ≥ 18 years of
age, had completed < 20 weeks gestation,
spoke English or Spanish, and were Medi-Cal
eligible. A total of 601 women agreed to par-
ticipate in the study, resulting in 538 live
births. Excluded from these analyses were par-
ticipants with insufficient serum volume for
PCB analyses (n = 118), no locatable TSH
data or only diagnostic information (n = 111),
missing neonatal age at the time of blood draw
(n = 22), and twins (n = 2). Women included
in analyses (n = 285) were similar to those
excluded except in that they had spent less
time in the United States than excluded
women. This study was approved by the
University of California, Berkeley, Committee
for the Protection of Human Subjects. All
participants gave written informed consent
before inclusion in the study.
Interviews. Participants were interviewed
during pregnancy as well as shortly after deliv-
ery in English or Spanish by bilingual, bicul-
tural staff. Sociodemographic information
collected included maternal age, family
income, the number of people supported by
this income, country of birth, and number of
years lived in the United States. Information
on alcohol, tobacco, drug, and caffeine con-
sumption as well as agricultural work was also
collected. 
Measurement of neonatal TSH. TSH is
routinely measured by the California
Department of Health Services Genetic
Diseases Branch as part of the state’s Neonatal
Screening Program. Samples were collected by
heel stick and deposited on a filter paper,
which was left to dry at room temperature.
Dried blood spots were then analyzed with a
solid-phase, time-resolved sandwich ﬂuoroim-
munoassay (AutoDELFIA; PerkinElmer,
Wellesley, MA) using a lanthanide metal
europium (Eu) label. These data were
abstracted from medical records. On average,
blood spot samples were collected 25 hr after
birth (range, 4–121 hr).
Measurement of PCBs in maternal serum.
Blood samples were collected by venipuncture
at the end of the second trimester (mean ±
SD gestational age = 26.1 ± 2.9 weeks) and
shortly before delivery. Delivery samples were
only included in the few cases when the sec-
ond-trimester sample was not collected (n =
19). Samples were processed at NMC and
stored at –80°C until shipment on dry ice to
the CDC in Atlanta, Georgia, for analysis.
We measured a total of 34 PCB congeners
(International Union for Pure and Applied
Chemistry nos. 18, 28, 44, 49, 52, 66, 74,
87, 99, 101, 118, 128, 138, 146, 149, 151,
153, 156, 157, 167, 170, 172, 177, 178, 180,
183, 187, 189, 194, 195, 196, 199, 206, 209)
by high-resolution gas chromatography/high-
resolution mass spectrometry with isotope
dilution quantiﬁcation based on methods pre-
viously published (Barr et al. 2003). Quality
control samples were included in each run.
Simple substitution methods, which consist
of assigning values when measurements are
below the limit of detection (LOD) such as
LOD/2 or LOD/√2, may bias results when
detection frequencies are < 90–95% (Lubin
et al. 2004). Values below the LOD were
therefore randomly imputed from a log-nor-
mal distribution whose parameters were
determined by maximum likelihood estima-
tion. This method generally produces unbi-
ased parameter estimates (Lubin et al. 2004).
LODs for PCBs ranged between 0.01 and
1.92 ng/g lipids. Statistical analyses were
restricted to PCB congeners with a detection
frequency > 75% and included PCBs 18, 28,
Prenatal PCB exposure and neonatal TSH
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153, 156, 180, 183, 187, 194, and 199.
Triglycerides and total cholesterol were
determined using standard enzymatic methods
(Roche Chemicals, Indianapolis, IN). Total
blood lipid concentrations were then calculated
using the method reported by Phillips et al.
(1989). PCB values were lipid-adjusted for all
analyses by dividing serum PCB concentra-
tions by total blood lipid concentrations.
PCB groupings. PCB congeners were
grouped according to previously proposed
structure-based and mechanism-based group-
ings (Van den Berg et al. 2006; Wolff et al.
1997). Structure-based groupings were gener-
ated by summing the individual levels of
mono-ortho (PCBs 28, 66, 74, 118, 156, 157,
167, and 189) and di-ortho substituted (PCBs
18, 44, 49, 52, 87, 99, 101, 128, 138, 146,
153, 172, 180, and 194) PCBs. The mecha-
nism-based methods included the three
groupings proposed by Wolff et al. (1997)
and the TEQ method. We calculated TEQs
using the World Health Organization’s toxic
equivalency factors (TEFs) (Van den Berg
et al. 2006). In addition, we created a priori
another mechanism-based grouping of PCBs
according to their ability to induce UPD-GT,
CYP1A [or 7-ethoxyresorufin-O-deethylase
(EROD)] and CYP2B [or 7-pentoxyresoruﬁn-
O-dealkylase (PROD)] in mammals. PCB
congeners likely to induce these enzymes were
identified through a search in PubMed
(http://www.ncbi.nlm.nih.gov/sites/entrez)
and through referenced articles (Table 1).
PCB congeners were considered enzyme
inducers if a continuous linear or nonlinear
dose response could be identified without
otherwise overt toxic effects. Doses necessary
to induce microsomal enzymes vary among
animal species and strains tested (Boobis et al.
1990). We considered a dose–response rela-
tionship in at least one strain for UDP-GT,
CYP1A, or CYP2B as an indication of possi-
ble UDP-GT induction in humans. PCB
congeners in the final grouping included
PCBs 52, 99, 101, 118 153, 156, 157, 167,
180, 183, 187, 189, 194, and 199. Because
dioxin-like PCBs induce CYP1A, the enzyme
inducers grouping included these congeners.
Statistical analyses. We used Pearson’s
correlations to evaluate the interrelationship
of PCB congeners. We then used one-way
analysis of variance (ANOVA) to compare
PCB levels by demographic characteristics.
We constructed multiple linear regression
models to test the association of both individ-
ual PCB congeners as well as PCB groupings
with neonatal TSH levels. Covariates consid-
ered in regression models included (catego-
rized as shown in Table 2 or as indicated
below): maternal age (continuously), race,
country of birth, marital status (married or
not), years of education, prepregnancy body
mass index (BMI; continuously); cigarette,
alcohol, and caffeine consumption during
pregnancy (none vs. any); gestational age at
time of blood collection for PCB analysis
(continuously); and neonate’s birth weight
(continuously), sex, gestational age at birth
(continuously), birth order (continuously),
and age (in hours) at the time of heel stick
(continuously). Covariates were selected for
ﬁnal models if they were related with the out-
come (p < 0.20); final models included
neonatal age at the time of heel stick, gesta-
tional age at birth, infant birth weight, sex,
and mother’s prepregnancy BMI. 
We also considered the potential con-
founding effect of other environmental chemi-
cals such as lead, organophosphate pesticides,
and other organochlorine compounds includ-
ing o,p′-dichlorodiphenyltrichloroethane
(DDT), p,p′-DDT, p,p′-dichlorodiphenyl-
trichloroethylene (DDE), β- and γ-hexachloro-
cyclohexane, dieldrin, hexachlorobenzene,
heptachlor epoxide, mirex, oxychlordane,
and trans-nonachlor. Organochlorine com-
pounds were measured concurrently with
PCBs using the method described above and
were lipid-adjusted. We determined exposure
to organophosphate pesticides by averaging the
concentration of dialkyl phosphate metabolites
measured in urine by high-resolution gas
chromatography–tandem mass spectrometry
with isotope dilution quantiﬁcation; these sam-
ples were collected twice during pregnancy
(mean gestational age, 13 and 26 weeks)
(Bradman et al. 2005; Bravo et al. 2004;
Eskenazi et al. 2004). We measured lead in
maternal and cord blood using graphite fur-
nace atomic absorption spectrophotometry. 
TSH levels surge at birth and decrease
sharply within the ﬁrst days of life, the period
during which blood was collected for TSH
analysis. Neonate’s age at the time of blood col-
lection (expressed in hours) was negatively asso-
ciated with both PCBs and TSH in our data.
Log10(age) maximized the correlation between
age at the time of blood collection and
log10(TSH) and was entered as such in the
models (r = –0.6, p < 0.001). As an alternative,
we also age-standardized TSH levels based on
data obtained from the neonatal screening pro-
gram administered by the Genetics Disease
Branch of the California Department of Health
(http://www.dhs.ca.gov/pcfh/gdb/html/NBS/)
(n = 1,330,213).
The concentrations of the different PCB
congeners are usually highly intercorrelated,
so the association of a specific grouping
with neonatal TSH may be attributed to
Chevrier et al.
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Table 1. References supporting microsomal enzyme induction by individual PCB congeners in animals.
PCB Microsomal enzymes
congener UDP-GT CYP1A/EROD CYP2B/PROD
42 Connor et al. 1995
47 Connor et al. 1995
52 Connor et al. 1995
77 Desaulniers et al. 1997; Chu et al. 1995;
Seo et al. 1995;  Morse et al. 1995;
Visser et al. 1993 Seo et al. 1995
99 Connor et al. 1995
101 Connor et al. 1995
105 Chu et al. 1998 Chu et al. 1998 Chu et al. 1998;
Connor et al. 1995
118 Chu et al. 1995;  Connor et al. 1995
Connor et al. 1995;
Kuriyama et al. 2003
126 Craft et al. 2002; Chu et al. 1994;
Seo et al. 1995; Craft et al. 2002;
Van Birgelen et al. 1995 Desaulniers et al. 1999; 
Seo et al. 1995; 
Van Birgelen et al. 1995
128 Lecavalier et al. 1997
149 Li et al. 2001
153 Craft et al. 2002 Chu et al. 1996; Connor et al. 1995;
Desaulniers et al. 1999 Craft et al. 2002; 
Desaulniers et al. 1999;
Ikegwuonu et al. 1996
154 Connor et al. 1995
156 Van Birgelen et al. 1995 Van Birgelen et al. 1994 Van Birgelen et al. 1994
163 Connor et al. 1995
169 Morse et al. 1993 Morse et al. 1993 Morse et al. 1993
170 Connor et al. 1995
180 Connor et al. 1995
183 Connor et al. 1995
187 Connor et al. 1995
189 Connor et al. 1995
194 Connor et al. 1995
199 Connor et al. 1995uncontrolled confounding by PCB congeners
not included in models. Therefore, we also
included the sum of those PCB congeners
that were not part of any particular grouping
in each model.
As described above, we ran multiple mod-
els to examine associations of neonatal TSH
with individual PCB congeners. The
Bonferroni adjustment method may be too
conservative when a large number of tests are
carried out. We therefore used the bootstrap-
based single-step maxT multiple testing pro-
cedure proposed by Dudoit et al. (2004),
which adjusts for multiple hypothesis testing
while accounting for the correlation between
exposures by estimating the joint distribution
of test statistics (multtest package in R; R
Foundation for Statistical Computing,
Vienna, Austria).
Adding congeners assumes an equal
potency for every component of a given group-
ing, which may not be appropriate. Thus, we
also analyzed the data by using principal-com-
ponent analysis to summarize both the group
of enzyme inducers and congeners that have
not been identiﬁed as enzyme inducers. Scores
for each group’s first component (defined as
the loadings-weighted sum of PCB congeners)
were then entered as the independent variable
in a multiple linear regression model along
with the covariates identiﬁed above. 
Missing values for PCB congeners were
imputed based on a nearest neighbor
(Euclidian distance) method (impute package
in R). Values for environmental exposures
(including PCBs) and TSH were expressed on
the log10 scale for statistical analyses. Analyses
were performed with Intercooled STATA,
version 8.1 (StataCorp., College Station, TX)
and R, version 2.3.0 (R Foundation for
Statistical Computing, Vienna, Austria).
Results
Most participating women were young,
Latina, born in Mexico, and had little educa-
tion (Table 2). Almost all spoke Spanish at
home (94%), and most were below the fed-
eral poverty line (61%) and had at least one
household member working in agriculture
(76%). There were slightly more male than
female children (52 vs. 48%). Approximately
3% of the newborns had a low birth weight
(< 2,500 g), and 8% were premature (< 37
weeks gestation).
TSH levels were within the reference range
for all children (≤ 25 mIU/L) with a geometric
mean of 5.7 mIU/L [95% conﬁdence interval
(CI), 5.3 to 6.1]. Gestational age at birth and
birth weight were positively associated with
TSH levels (data not shown). No other covari-
ates were related to TSH levels. 
The sum of those PCB congeners with a
detection frequency > 75% increased with
maternal age (p < 0.001) and with the num-
ber of years of education (p < 0.05; Table 3).
Levels were also higher in women who
smoked during pregnancy, but the difference
was not statistically signiﬁcant. 
Only PCBs 183 (β = 0.11; 95% CI, 0.02
to 0.20) and 199 (β = 0.10; 95% CI, 0.01 to
0.20) were significantly positively related to
neonatal TSH levels in univariate regressions
(data not shown); however, as shown in
Table 4, 6 of the 19 PCB congeners detected
in > 75% of the samples—namely PCBs 101,
180, 183, 187, 194, and 199—were found to
Prenatal PCB exposure and neonatal TSH
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Table 2. Demographic characteristics in a popula-
tion of pregnant women and their children in the
Salinas Valley, CA (n = 285). 
Sum PCBs (ng/g lipids)a
Geometric
No. (%) mean 95% CI
Maternal
Age (years)
18–24 142 (50) 54.1 49.2–59.5*#
25–29 89 (31) 59.9 53.1–67.5
30–34 35 (12) 72.9 60.2–88.3
35–45 19 (7) 87.5 72.3–105.9
Race
White 3 (1) 38.9 9.7–156.3
Latina 275 (96) 59.9 55.9–64.2
Other 7 (2) 67.3 50.2–90.3
Education
≤ 6th grade 118 (41) 55.7 50.1–62.0#
7–12th grade 100 (35) 59.4 53.0–66.5
≥ High school 67 (23) 68.5 60.1–78.1
Income (% poverty)
< 100 162 (61) 59.3 54.3–64.7
100–200 96 (36) 60.5 53.7–68.2
> 200 9 (3) 49.1 29.9–80.4
Country of birth
United States 34 (12) 61.9 50.0–76.5
Mexico 244 (86) 59.8 55.6–64.3
Other 7 (3) 52.0 34.5–78.6
Time in the USA (years)
≤ 5 156 (55) 59.0 53.7–64.7
6–10 69 (24) 61.3 53.4–70.4
≥ 11 60 (21) 60.4 52.5–69.5
Parity
0 103 (36) 61.6 54.8–69.2
≥ 1 183 (64) 58.8 54.2–63.9
Smoking during pregnancy
Yes 12 (4) 68.7 48.5–97.3
No 274 (96) 59.5 55.5–63.7
Infant
Sex
Male 147 (52) 58.2 52.9–63.9
Female 138 (48) 61.6 56.0–67.8
Birth weight (g)
< 2,500 9 (3) 66.8 49.9–89.4
2,500–3,500 150 (52) 58.6 53.3–64.4
> 3,500 126 (44) 60.8 55.0–67.2
Gestational age at birth (weeks)
< 37 22 (8) 61.4 49.7–75.7
37–42 264 (92) 59.7 55.6–64.1
> 42 0 (0) — —
aPCBs with a detection frequency ≥ 75% were summed.
*p < 0.05 ANOVA. #p < 0.05 linear trend by Pearson’s
correlation. 
Table 3. PCB levels (geometric means), detection frequencies, ranges, and LOD ranges in a population of
pregnant women in the Salinas Valley, CA.
Detection Geometric
No. LOD range frequency (%) mean 95% CI Range
ΣPCBsa (ng/g) 285 0.02–1.92 100 59.8 56.0–64.0 15.3–323.7
TEQ (pg/g) 285 0.004–0.086 100 0.86 0.75–0.97 < LOD–5.17
Inducersb (ng/g) 285 0.03–1.44 100 38.9 36.3–41.6 10.0–250.3
Mono-orthoc (ng/g) 285 0.03–1.11 100 29.4 27.2–31.7 6.4–127.7
Di-orthod (ng/g) 285 0.03–1.44 100 27.6 25.9–29.5 7.3–213.1
Wolff method
Group 1e (ng/g) 285 0.03–1.92 100 8.3 7.6–9.1 0.4–62.9
Group 2f (ng/g) 285 0.03–1.11 100 13.2 12.3–14.1 2.1–69.1
Group 3g (ng/g) 285 0.04–1.09 100 8.4 7.7–9.1 0.6–138.0
Individual congeners
PCB-18 (ng/g) 279 0.03–0.88 100 6.5 5.9–7.1 0.9–32.1
PCB-28 (ng/g) 285 0.03–0.79 100 17.4 15.8–19.1 3.1–91.7
PCB-44 (ng/g) 238 0.06–1.92 98.7 2.3 2.1–2.6 < LOD–11.4
PCB-49 (ng/g) 250 0.05–1.40 99.2 1.5 1.4–1.7 < LOD–7.9
PCB-52 (ng/g) 261 0.05–1.89 99.2 3.0 2.7–3.3 < LOD–12.4
PCB-66 (ng/g) 276 0.39–1.02 100 2.8 2.5–3.0 0.4–16.0
PCB-74 (ng/g) 276 0.04–1.11 100 4.1 3.8–4.4 0.7–20.8
PCB-99 (ng/g) 263 0.06–1.09 100 1.8 1.7–1.9 0.5–11.6
PCB-101 (ng/g) 241 0.06–1.44 94.6 0.9 0.8–1.1 < LOD–5.8
PCB-118 (ng/g) 270 0.05–0.86 99.6 3.4 3.2–3.7 < LOD–4.7
PCB-138 (ng/g) 263 0.03–0.65 100 2.5 2.3–2.7 0.2–30.9
PCB-146 (ng/g) 249 0.05–0.60 87.6 0.5 0.4–0.5 < LOD–14.7
PCB-153 (ng/g) 273 0.04–0.70 100 5.6 5.2–6.0 0.3–95.6
PCB-156 (ng/g) 270 0.07–0.55 85.2 0.4 0.4–0.5 < LOD–6.3
PCB-180 (ng/g) 231 0.06–0.96 100 1.5 1.4–1.7 0.3–30.0
PCB-183 (ng/g) 259 0.06–0.47 78.0 0.3 0.3–0.4 < LOD–8.2
PCB-187 (ng/g) 224 0.04–0.71 96.9 0.9 0.8–1.0 < LOD–38.3
PCB-194 (ng/g) 263 0.03–0.50 95.4 0.5 0.5–0.6 < LOD–8.6
PCB-199 (ng/g) 271 0.03–0.62 85.6 0.4 0.3–0.4 < LOD–7.5
aSum of all PCBs with a detection frequency ≥ 75% (listed above). bEnzyme inducers include PCBs 52, 99, 101, 118, 153,
156, 180, 183, 187, 194, and 199. cMono-ortho PCBs include PCBs 28, 66, 74, 118, and 156. dDi-ortho PCBs include PCBs 18,
44, 49, 52, 99, 101, 138, 146, 153, 180, and 194. eGroup 1 includes PCBs 44, 49, 52, 101, 187, and 199. fGroup 2 includes PCBs
66, 74, 118, 138, and 156. gGroup 3 includes PCBs 99, 153, 180, and 183.be significantly related to TSH levels, after
adjustment for neonatal age at the time of
blood draw (β = 0.08–0.14, p < 0.05). Three
additional congeners, PCBs 99, 138, and
153, were significantly positively related to
TSH after adjustment for all covariates (PCB-
99: β = 0.11; 95% CI, 0.02 to 0.21; PCB-
138: β = 0.09; 95% CI, 0.01 to 0.18 and
PCB-153: β = 0.08; 95% CI, 0.00 to 0.17).
PCBs 194 and 199 remained signiﬁcantly
associated with TSH levels after adjustment
for multiple hypothesis testing (PCB-194: β =
0.12; 95% CI, 0.01 to 0.24; PCB-199: β =
0.14; 95% CI, 0.02 to 0.25), whereas PCBs
101, 183, and 187 almost reached statistical
significance (PCB-101: β = 0.09; 95% CI,
–0.01 to 0.18; PCB-183: β = 0.13; 95% CI,
–0.01 to 0.23; PCB-187: β = 0.09; 95% CI,
–0.01 to 0.20).
Total PCB levels, structure-based group-
ings (mono-ortho and di-ortho substituted
PCBs), and the TEQ of dioxin-like PCBs
were not signiﬁcantly associated with neonatal
TSH levels (Table 4). However, the sum of
PCBs specifically hypothesized to induce
T4-metabolizing enzymes was positively asso-
ciated with neonatal TSH levels; each 10-fold
increase in the sum of enzyme-inducing PCBs
was associated with a 29% (95% CI, 2 to
62%) increase in TSH (computed from Table
4). The association was linear on a log–log
scale, as shown in Figure 1. Including the
sum of PCBs not found to be enzyme induc-
ers in the same model or removing extreme
values did not materially alter results (data
not shown). The principal-component analy-
sis–computed factor summarizing the serum
level of potential enzyme inducers (account-
ing for 64% of the variance) was also signiﬁ-
cantly associated with neonatal TSH (β =
0.015, 95% CI, 0.005 to 0.024), whereas the
factor representing noninducers (accounting
for 63% of the variance) was not (β = 0.006,
95% CI, –0.005 to 0.017). Furthermore, the
sum of congeners included in group 3 of the
classiﬁcation proposed by Wolff et al. (1997),
which is also based on enzyme induction, was
signiﬁcantly associated with TSH levels (β =
0.11; 95% CI, 0.02 to 0.20). The fact that we
found a significant association with the sum
of all potential enzyme inducer PCBs but not
with the TEQ suggests that CYP2B inducers
were primarily associated with TSH. This was
conﬁrmed when we grouped PCBs by speciﬁc
enzyme induced (CYP2B/PROD inducers:
β = 0.11; 95% CI, 0.01 to 0.21). 
Results above were similar whether
neonate’s age at the time of TSH measurement
was controlled for by including the variable as
a covariate in models or by standardizing with
the use of an external population (California
Department of Health Services, Genetic
Diseases Branch). The method used to account
for blood lipids (including it as a covariate or
expressing PCBs on a lipid basis) did not
appreciably alter results.
Discussion
Results from this study suggest that prenatal
exposure to PCB congeners that induce
CYP2B in animals is positively associated
with TSH levels in children shortly after
birth. In animals, UDP-GT (UGT1A1) is
induced concurrently with CYP2B following
exposure to phenobarbital-like compounds,
which may explain the observed association
(Sugatani et al. 2001). However, we found no
association between levels of TSH and total
PCBs, PCBs grouped by structure (mono-
and di-ortho–substituted PCBs), or dioxin-
like PCBs (TEQ). These findings were
observed in the CHAMACOS population,
which had low exposure to PCBs compared
with the general U.S. population (CDC
2005). The median PCB-153 concentration,
for instance, was 5.6 times lower in our par-
ticipants than in the NHANES (National
Health and Nutritional Examination Survey)
sample (5.4 vs. 30.1 ng/g lipids).
Our findings differ from those of
Koopman-Esseboom et al. (1994), who found
associations between maternal dioxin-like
PCBs (TEQ) and neonatal TSH levels, and of
Wang et al. (2005), who reported associations
between the placental dioxin/PCB TEQ and
cord blood TSH levels. Although we may
have underestimated the TEQ in our popula-
tion because we did not measure the levels of
two key dioxin-like PCBs (PCBs 126 and
169), the exposure level in the Dutch study
appeared to be substantially higher (about 20
times) than in the current study (Longnecker
et al. 2003). Our results also differ from those
of previous studies that found no association
of TSH levels with individual PCB congeners
(Ribas-Fito et al. 2003; Takser et al. 2005).
However, our findings are consistent with
those of Longnecker et al. (2000), Takser
Chevrier et al.
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Table 4. Age-adjusted and fully adjusted associa-
tions between prenatal exposure to PCBs and
neonatal TSH levels. 
Age-adjusted Fully adjusteda
β 95% CI β 95% CI
ΣPCBsb 0.05  –0.05 to 0.15 0.06  –0.05 to 0.16
TEQ –0.01 –0.10 to 0.08 0.00 –0.10 to 0.09
Inducersc 0.09 –0.01 to 0.19 0.11 0.01 to 0.21
Mono-orthod 0.01 –0.08 to 0.10 0.01 –0.08 to 0.10
Di-orthoe 0.08 –0.03 to 0.19 0.09 –0.02 to 0.20
Wolff method
Group 1f 0.05 –0.04 to 0.14 0.06 –0.03 to 0.14
Group 2g 0.04 –0.07 to 0.14 0.05 –0.06 to 0.16
Group 3h 0.09 0.00 to 0.18 0.11 0.02 to 0.20
Individual congeners
PCB-18 0.03 –0.05 to 0.10 0.03 –0.04 to 0.10
PCB-28 0.01 –0.06 to 0.08 0.02 –0.06 to 0.08
PCB-44  0.03 –0.05 to 0.10  0.03 –0.04 to 0.11
PCB-49 0.02 –0.06 to 0.09 0.02 –0.05 to 0.09
PCB-52 0.03 –0.05 to 0.11 0.03 –0.05 to 0.11
PCB-66 0.00 –0.08 to 0.08 0.01 –0.07 to 0.09
PCB-74 0.03 –0.07 to 0.12 0.03 –0.06 to 0.13
PCB-99 0.09 –0.00 to 0.18 0.11 0.02 to 0.21
PCB-101 0.08 0.02 to 0.15 0.09 0.03 to 0.16
PCB-118 0.01 –0.08 to 0.11 0.03 –0.07 to 0.13
PCB-138 0.07 –0.01 to 0.15 0.09 0.01 to 0.18
PCB-146 0.06 –0.02 to 0.14 0.07 –0.01 to 0.15
PCB-153 0.07 –0.01 to 0.15 0.08 0.00 to 0.17
PCB-156 0.04 –0.03 to 0.11 0.05 –0.03 to 0.12
PCB-180 0.08 0.00 to 0.15 0.09 0.01 to 0.17
PCB-183 0.12 0.05 to 0.19 0.13 0.05 to 0.20
PCB-187 0.09 0.02 to 0.16 0.09 0.02 to 0.17
PCB-194 0.11 0.03 to 0.19 0.12 0.04 to 0.20
PCB-199 0.14 0.07 to 0.22 0.14 0.07 to 0.22
aModels adjusted for neonatal age at time of heel stick for
TSH measurement, gestational age at birth, infant birth-
weight, sex and mother’s prepregancy BMI. bSum of all
PCBs with a detection frequency ≥ 75%. cEnzyme inducers
include PCBs 52, 99, 101, 118, 153, 156, 180, 183, 187, 194,
and 199. dMono-ortho PCBs include PCBs 28, 66, 74, 118,
and 156. eDi-ortho PCBs include PCBs 18, 44, 49, 52, 99, 101,
138, 146, 153, 180, and 194. fGroup 1 includes PCBs 44, 49,
52, 101, 187, and 199. gGroup 2 includes PCBs 66, 74, 118,
138, and 156. hGroup 3 includes PCBs 99, 153, 180, and 183.
Figure 1. Association between covariate-adjusted TSH levels and the sum of microsomal enzyme-inducing
PCB congeners in neonates (n = 285).
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Fitted valueset al. (2005), and Ribas-Fito et al. (2003),
who did not ﬁnd an association between the
sum of all PCB congeners measured and TSH
levels in pregnant women, neonates, and cord
blood. Our results also agree with the lack of
association between the structure-based
grouping of mono-ortho–substituted PCB
congeners and TSH levels, as reported in two
previous studies (Takser et al. 2005; Wang
et al. 2005).
Serum concentrations of PCB congeners
are highly intercorrelated, yet individual con-
geners may differ in their health effects and
mechanisms of action. Except for a study by
Wolff and Toniolo (1995), who investigated
associations with breast cancer, we are not
aware of any other study that grouped PCBs
based on the mechanism of enzyme induc-
tion. To date, no study examining the poten-
tial of PCBs to disrupt TH has grouped
congeners based on their potential to speciﬁ-
cally disrupt TH.
One of the main strengths of this study is
that we attempted to characterize a priori PCB
congeners based on their potential to affect
TH. We grouped PCBs based on evidence
from animal studies suggesting the potential of
speciﬁc PCB congeners to induce UDP-GT.
We also considered the potential confounding
effect of a large number of demographic and
environmental covariates. Our findings were
further supported by principal-component
analysis, with the first factor summarizing
enzyme-inducing congeners being signiﬁcantly
associated with neonatal TSH levels whereas
the factor summarizing other congeners was
not. Strengths also include the control for mul-
tiple hypothesis testing and our use of distribu-
tion-based imputation techniques for values
below the LOD.
There are limitations to the method we
propose, some of which stem from limited
data. First, we could not ﬁnd published data
for seven of the 19 congeners commonly found
in the CHAMACOS population (detection
frequency > 75%). Also, our method does not
consider other potential mechanisms of action
by which PCBs could affect TH levels, includ-
ing the binding of PCBs to transthyretin and
displacement of T4 (Chauhan et al. 2000),
increased liver T4 uptake and decreased pitu-
itary sensitivity to thyroid-releasing hormone
(Khan and Hansen 2003), altered T4 and T3
synthesis (Collins and Capen 1980), and
inhibited thyroid gland response to TSH
(Byrne et al. 1987). Summing the concentra-
tions of PCB congeners also assumes equal
potencies, which may not be appropriate.
Summarizing the grouping with principal-
component analysis–derived factors, though
avoiding the equal potencies assumption of the
summation method, still assumes no syner-
gistic effect. An ideal grouping would consider
all potential mechanisms of action, different
relative potencies, and interactions. One strat-
egy to improve our method might be to
develop a TEQ-like weighing system (Van den
Berg et al. 2006). Such a scheme would require
more congener-speciﬁc data and would need to
consider whether a simple linear additive
model appropriately represents observed effects
at environmentally relevant doses.
In summary, we report a positive associa-
tion between neonatal TSH levels and prena-
tal exposure to PCBs reported to induce
microsomal enzymes (specifically CYP2B)
and suspected to induce UDP-GT in animals
but not with the sum of all PCB congeners,
or PCBs grouped according to their dioxin-
like activity or structure. This is the largest
study to date investigating prenatal exposure
to PCBs and neonatal TSH. If replicated, our
findings would support the hypothesis that
not all PCB congeners disrupt thyroid hor-
mones, and would argue against summing all
PCB congeners. However, they would sup-
port grouping PCB congeners based on their
potential mechanism of action of UDP-GT
induction. Our results also suggest that PCBs
affect TH homeostasis even at the low back-
ground level of exposure found in the
CHAMACOS population. Although TSH
remained within the reference range, previous
animal and human studies suggest that mater-
nal hypothyroxinemia (low free T4 and nor-
mal TSH levels) during early pregnancy
adversely affects neurodevelopment (Morreale
de Escobar et al. 2000; Pop et al. 1999).
Future studies should examine whether TH
levels within the reference range in neonates
may be related to neurodevelopment. 
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